Tissue specificity of DNA damage response and tumorigenesis

The genome of cells is constantly challenged by DNA damages from endogenous metabolism and environmental agents. These damages could potentially lead to genomic instability and thus to tumorigenesis. To cope with the threats, cells have evolved an intricate network, namely DNA damage response (DDR) system that senses and deals with the lesions of DNA. Although the DDR operates by relatively uniform principles, different tissues give rise to distinct types of DNA damages combined with high diversity of microenvironments across tissues. In this review, we discuss recent findings on specific DNA damage among different tissues as well as the main DNA repair way in corresponding microenvironments, highlighting tissue specificity of DDR and tumorigenesis. We hope the current review will provide further insights into molecular process of tumorigenesis and generate new strategies for cancer treatment.

A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis

Cell type-specific properties and environment shape tissue specificity of cancer genes

PDF) Tissue specificity of DNA damage response and tumorigenesis

Frontiers DNA Damage-Induced Inflammatory Microenvironment and Adult Stem Cell Response

Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy - ScienceDirect

Tissue specificity of DNA damage response and tumorigenesis

The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics

Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells, Cell & Bioscience

New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy

DNA damage—how and why we age?

DNA Damage Response – An Emerging Target for Groundbreaking Cancer Therapies

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy